03-01-2018 10:22 AM CET - Health & Medicine
Print

Non-Alcoholic Steatohepatitis Key Players - AstraZeneca Plc, BASF SE, CymaBay Therapeutics Inc, and Daiichi Sankyo Co Ltd Market Analysis & Forecast 2018-2022

Press release from: WiseGuy Research consultants Pvt Ltd.
PR Agency: WISEGUY RESEARCH CONSULTANTS PVT LTD
Non-Alcoholic Steatohepatitis 
Non-Alcoholic Steatohepatitis 


Non-Alcoholic Steatohepatitis 

Overview

Non-alcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. NASH can get worse and cause scarring of the liver, which leads to cirrhosis. Symptoms of NASH include fatigue, weight loss for no clear reason, general weakness and an ache in the upper right part of belly. Risk factors include obesity, type 2 diabetes, high cholesterol and high triglycerides and metabolic syndrome.

Click here for sample report @ www.wiseguyreports.com/sample-request/2811463-non-alcohol...

Top Companies mentioned

AstraZeneca Plc

BASF SE

CymaBay Therapeutics Inc

Daiichi Sankyo Co Ltd

Viking Therapeutics Inc

Zebra Discovery Ltd

Non-Alcoholic Steatohepatitis Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Non-Alcoholic Steatohepatitis   - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Non-Alcoholic Steatohepatitis  , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Non-Alcoholic Steatohepatitis (NASH) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 6, 32, 28, 6, 84, 35 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 3 and 1 molecules, respectively.

Non-Alcoholic Steatohepatitis pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Non-Alcoholic Steatohepatitis - Competitive Analysis

Key players are making innovative developments in Non-Alcoholic Steatohepatitis industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Non-Alcoholic Steatohepatitis.

The pipeline guide reviews pipeline therapeutics for Non-Alcoholic Steatohepatitis by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Non-Alcoholic Steatohepatitis therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Non-Alcoholic Steatohepatitis therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Non-Alcoholic Steatohepatitis.

.Continued

For Detailed Reading Please visit @ www.wiseguyreports.com/reports/2811463-non-alcoholic-stea...

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.
News-ID: 962143 • Views: 367
More releases More releases

You can edit or delete your press release here: